migraine headaches

Migraine Pipeline and Impact Updates: What Health Execs Should KnowA new report highlights physical, social, and economic challenges of migraine.
Novel drug reduces monthly migraine daysA global phase 3 study of erenumab (Amgen and Novartis) showed that the drug was able to prevent migraines headaches.
‘Game changing’ migraine drugs on the horizonThere’s no silver bullet for migraine treatments, but treatments are getting more precise as we learn more about the cause of migraines.
Acute migraine sufferers may find relief with beta-blocker eye dropsA small case series of patients has shown that use of beta-blocker drops may be a simple and inexpensive way to eliminate pain in patients with acute migraines.
Pediatric migraine drug gets FDA green lightFDA has approved sumatriptan and naproxen sodium (Treximet, Pernix Therapeutics) for the treatment of migraines in pediatric patients.
Teenager battles daytime sleep attacksA 17-year-old-male presented to a specialty clinic for follow-up of attention-deficit/hyperactivity disorder (ADHD), migraine headaches, adjustment disorder with mixed disturbance of emotion and conduct, and mood disorder. At this visit, he reported excessive daytime sleepiness that was interfering with academic tasks and “life.”
Study assesses best treatments to use when a migraine attack occursIt is important to ensure established migraine medications are available for the patients who need them, according to a new study published in the January issue of Headache.
Relieve migraines with tinted contact lensesOptometric practices offer tinted and colored contact lenses to aid in cosmetic enhancement; however, many eyecare practices are unaware of the therapeutic effects that tinting a lens (contact or spectacle) can offer.
FDA drug approvals: January 2014FDA approvals, complete response, fast-track designations, priority review, first-time generic approval
Migraines in Women Linked to Depression, SuicideA population-based Canadian study suggests that young, female migraineurs are at increased risk of suicidal ideation, pointing to a need for their physicians to screen them for depression. The results, published in Depression Research and Treatment, were by researchers from the University of Toronto.